Skip to main content
. 2021 Jun 30;13(13):3288. doi: 10.3390/cancers13133288

Figure 1.

Figure 1

The antitumor activity of datelliptium on RET expression. (A) Structure of datelliptium, (B) Western blot analysis of the expression of RET in TT and MZ-CRC-1 cells treated with datelliptium for 48 h. (C) Densitometry analysis of the western blotting results for RET was normalized to its basal expression (n = 3, **** p < 0.0001, and *** p < 0.001) using one-way ANOVA with Tukey post-test. (D) Immunofluorescence staining of the expression of RET in TT and MZ-CRC-1 cells treated with datelliptium for 48 h (×400, scale  =  50 μm); DAPI (blue stained nuclei).